STAT October 2, 2020
Sam Surette

Picture this: As a Covid-19 patient fights for her life on a ventilator, software powered by artificial intelligence analyzes her vital signs and sends her care providers drug-dosing recommendations — even as the same software simultaneously analyzes in real time the vital signs of thousands of other ventilated patients across the country to learn more about how the dosage affects their care and automatically implements improvements to its drug-dosing algorithm.

This type of AI has never been allowed by the Food and Drug Administration. But that day is coming.

AI that continuously learns from new data and modifies itself, called adaptive AI, faces some steep barriers. All FDA-cleared or approved AI-based software is “locked,” meaning the manufacturer cannot allow adaptations...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Technology
Amazon invests another $2.75B in Anthropic — reportedly ‘largest’ in company history
Policy at global conference focuses on three central issues
How Remote Patient Monitoring and AI Personalize Care
How Nebraska Medicine used AI to reduce first-year nurse turnover by nearly 50%
Social Isolation Linked to Being Older Than Biological Age, Greater Mortality

Share This Article